Discovery and Characterization of Novel CNS-Penetrant GPR55 Agonists
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c00784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Richard C Hewer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cerevance Limited, 418 Cambridge Science Park, Cambridge CB4 0PZ, U.K. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Cerevance Ltd.
Abstract (Originalsprache)
From our NETSseq-derived human brain transcriptomics data, we identified GPR55 as a potential molecular target for the treatment of motor symptoms in patients with Parkinson's disease. From a high-throughput screen, we identified and optimized agonists with nanomolar potency against both human and rat GPR55. We discovered compounds with either strong or limited β-arrestin signaling and receptor desensitization, indicating biased signaling. A compound that showed minimal GPR55 desensitization demonstrated a reduction in firing frequency of medium spiny neurons cultured from rat striatum but did not reverse motor deficits in a rat hypolocomotion model. Further profiling of several desensitizing and non-desensitizing lead compounds showed that they are selective over related cannabinoid receptors CB1 and CB2 and that unbound brain concentrations well above the respective GPR55 EC50 can be readily achieved following oral administration. The novel brain-penetrant GPR55 agonists disclosed can be used to probe the role of this receptor in the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cerevance Limited, 418 Cambridge Science Park, Cambridge CB4 0PZ, U.K.
- Aragen Life Sciences Ltd, Plot #284A (part), Bommasandra-Jigani Link Road Industrial Area, Bengaluru 562106, India.
ORCID-Profile: Richard C Hewer, Kevin J Doyle, Louise Dickson, Roland W Bürli
Förderung
- Cerevance Ltd
Zitieren
APA
Hewer, R. C., Christie, L. A., Doyle, K. J., Xu, X., Roberts, M. J., Dickson, L., Cheung, T., Cadwalladr, D. H., Pickford, P., Teall, M., Powell, J. A. C., Sheardown, S., Narayana, L., Brice, N. L., Dawson, L. A., Carlton, M., & Bürli, R. W. (2023). Discovery and Characterization of Novel CNS-Penetrant GPR55 Agonists. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00784
Vancouver
Hewer RC, Christie LA, Doyle KJ, Xu X, Roberts MJ, Dickson L, et al. Discovery and Characterization of Novel CNS-Penetrant GPR55 Agonists. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00784
BibTeX
@article{Hewer2023,
author = {Hewer, Richard C and Christie, Louisa A and Doyle, Kevin J and Xu, Xiao and Roberts, Maxine J and Dickson, Louise and Cheung, Toni and Cadwalladr, David H and Pickford, Philip and Teall, Martin and Powell, Justin A C and Sheardown, Steven and Narayana, Lakshminarayana and Brice, Nicola L and Dawson, Lee A and Carlton, Mark and Bürli, Roland W},
title = {Discovery and Characterization of Novel CNS-Penetrant GPR55 Agonists},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c00784}
}
EUVIMED